BBD Longitudinal Study of Osteogenesis Imperfecta

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorBaylor College of Medicine

About this trial

Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility characterized by fractures with minimal or absent trauma, dentinogenesis imperfecta (DI), and, in adult years, hearing loss. It is seen in both genders and all races. The clinical features of OI represent a continuum varying from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal stature, and normal lifespan. Fractures can occur in any bone, but are most common in the extremities. These disorders can be devastating and progressive and result in deformity, chronic pain, impaired function and loss of quality of life.

The overall goal of this study is to answer specific question about the natural history of brittle bone diseases as defined by molecular etiology and to develop the foundation for prospective clinical studies.

Eligibility criteria

Qualifiers

Individuals with OI diagnosed by molecular (DNA) analysis OR

Individuals whose clinical history and radiographs are highly suggestive of OI, but whose diagnosis has not been verified by biochemical or molecular studies

Disqualifiers

Individuals who are unable to return for their scheduled follow up visits.

Individuals with skeletal dysplasias other than OI

Individuals with OI and a second genetic or syndromic diagnosis

Use of a bone-acting treatment agent such as bisphosphonates, calcitonin, calcitriol, fluoride, etc., within one year of enrollment.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Baylor College of Medicine

Lead sponsor

Shriners Hospitals for Children

Collaborator

Hospital for Special Surgery, New York

Collaborator

Children's National Research Institute

Collaborator

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Collaborator

University of California, Los Angeles

Collaborator

Oregon Health and Science University

Collaborator

University of Nebraska

Collaborator

Alfred I. duPont Hospital for Children

Collaborator

University of South Florida

Collaborator

Phoenix Children's Hospital

Collaborator

Marquette University

Collaborator